As we expected, recent studies reported that DNA2 inhibition can sensitize breast cancer cells to chemotherapy inducing DNA damage.44 We developed a simple high-throughput screening assay for DNA2 inhibitors, which can screen compound collections in very small reaction volume and in general to screen for inhibitors of other nucleases. Here, DNA2 is linked to breast cancer.